Sorry for not being clear. I replied to Peter's post. Basically I think there is probably some value in the company around $30 but I am a long term investor and have trouble with the culture.
The book is slow and IMO goes on too much about the transplant drug. I did like getting a sense for how things go at Biotechs which can probably be summed up as chaos pursing money and drugs.